Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sodium Nitroprusside on Cerebral Blood Flow
NCT03317652Completed
- Sponsor
- Rigshospitalet
- Start
- Nov 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sodium nitroprusside, sponsored by Rigshospitalet. Primary endpoint: Change in Cerebral Blood Flow from Baseline to MAP -40% at 2 hours. Started Nov 2017; status: completed.
02
Drugs
sodium nitroprusside
Beyond the preview
Go deeper on NCT03317652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317652.